chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On February 27, I had a sore throat, nasal congestion, slight headache It was in the evening, and I went to bed. The next morning the symptoms were more so I took the at home COVID-19 test and I was positive. I called the PCP and they did a video call and then prescribed PAXLOVID and I started that afternoon. By the following day I was greatly improved my symptoms were just about gone. The next day which is day three I had no more symptoms. The next day I was clear, and I had been in isolation and day 10 all my symptoms came back. They all lasted for about three days. I then isolated for 5 days, and I had symptoms for 3 of them days. I was still testing positive 13 days out with no symptoms at all.
On 1/17/23, he had a common cold with an ear infection. He had congestion, fever, coughing, and difficulty breathing. We contacted his doctor and was prescribed Albuterol and Amoxicillin. We had to take him back to the doctor because he wasn't getting better, and they prescribed Cefdinir. This lasted until 2/6/23.
Fever over 101 F; Bed-bound; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number J225D, expiry date 22nd October 2021) for prophylaxis.   On 5th August 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced fever and bedridden. On an unknown date, the outcome of the fever and bedridden were recovered/resolved.   It was unknown if the reporter considered the fever and bedridden to be related to Shingrix.  Additional details were provided as follows: Following 1st dose of Shingrix vaccination in left deltoid, the patient complained of fever over 101 Fahrenheit for over 1.5 days and that she was bed-bound. The reporter had very limited event information and did not know onset of events. The outcome reported for all events in the structured field of XML is resolved with sequelae instead of recovered/ resolved (outcome uploaded in Argus).      Lab Comments: On an unknown date, the patients body temperature was checked
Pruritic rash surrounding polio and hib vaccine sites, also rash to trunk, legs, arms, immunization given 24 hours previously.
RECEIVED A DOSE OF THE VACCINE FROM A VIAL THAT HAD BEEN OPEN A WEEK PRIOR (FOUR PATIENTS); VIAL THAT HAD BEEN OPEN A WEEK PRIOR ADMINISTRATION OF VACCINE KEPT IN THE  FRIDGE THE WHOLE TIME; This spontaneous report received from a health care professional concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1820095, and expiry: 02-OCT-2021) dose was not reported, administered on 06-AUG-2021 for prophylactic vaccination. No concomitant medications were reported.  On 06-AUG-2021, the patient experienced received a dose of the vaccine from a vial that had been open a week prior (four patients). On 06-AUG-2021, the patient experienced vial that had been open a week prior administration of vaccine kept in the fridge the whole time. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the received a dose of the vaccine from a vial that had been open a week prior (four patients) and vial that had been open a week prior administration of vaccine was not reported. This report was non-serious.
I spent many many hours talking to the FDA (they were wonderful) talking to the pharmacy (where my husband & I received the flu shot), talking to doctors & nurses, waiting 5 hours in Emergency to get a CT; visiting a neurologist (which our family doctor, a fabulous doctor recommended) etc that I would prefer not to fill out any more forms right now. Both my husband & I had an immediate negative response to the flu shot (or following - beginning that evening, the flu shot) that I would prefer to just send you a photocopy of some of the medical records, and, with my permission, you may request any information from any doctor, that might help you, or others, to avoid this complication. Just as an update, I believe I am suffering from a second round of Bell's palsy (as noted on doctor's report). My left side - lip & toes are going numb again. I'm losing weight, I think because I don't taste foods the way I used to, due to the partial paralysis of my tongue. I believe I may have had a negative to the mercury in the flu shot, so next year, I will request a preservative free shot. Diagnosis: Transient cerebral ischemia.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult female patient who received Flu vaccine for prophylaxis. On an unknown date, the patient received Flu vaccine (intramuscular). On an unknown date, less than a day after receiving Flu vaccine, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain to be related to Flu vaccine. Additional details were provided as follows: The age at vaccination was not reported. The patient received flu vaccine on an unknown arm but she could not recall the name of the vaccine and experienced pain in arm at the injection site which lasted for a few days and then resolved. No additional details were available. The patient denied permission to contact their physician.
p/vax pt seen by MD w/persistent crying possibly d/t abd pain;it was determined that pt had an elevated ESR;
MMR given 08/27/02 Welt 4mm, 09/05/02 ill visit adm with diarrhea and dehydration, Stay at 1 day, On 09/14/02 adm via ER, Rectal Temp - 106, Seizure viral illness. Reporting because it is in 30 days period of MMR.
Muscle ache in his both arms where both dose vaccines injected; Muscle aches in the left arm where the shot was injected; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 01, Anatomical location: Arm Right), administration date: 29Mar2021, for COVID-19 Immunization, reaction(s): "unable to sleep on his right arm", "Muscle ache in his both arms where both dose vaccines injected". The following information was reported: MYALGIA (non-serious) with onset 2021, outcome "not recovered", described as "Muscle ache in his both arms where both dose vaccines injected"; VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "not recovered", described as "Muscle aches in the left arm where the shot was injected". Therapeutic measures were taken as a result of myalgia, vaccination site pain. Additional Information: The patient stated that he had muscle aches in the left arm where the shot was injected but, it is not as prominent. He has massaged and took hot baths to try to relieve the aches but has not helped. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
1.  one day after the injection I developed a 3"  x  3" round by 1/4" thick area around the injection site, warm, tender, and itchy that lasted 5 days --  plus another 4 days after that to slowly go away.   2.  one day after the injection I developed chills and fatigue that lasted less than 24 hours, then I felt fine.
Patient complained of ankle swelling and redness the night of receiving HPV vaccine. Overnight, progressed to pain, redness, and swelling of knees bilaterally.
Migraine; This spontaneous case was reported by an other health care professional and describes the occurrence of MIGRAINE (Migraine) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 040A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MIGRAINE (Migraine). At the time of the report, MIGRAINE (Migraine) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported.
Information has been received from a consumer concerning his 14 year old daughter who was vaccinated with GARDASIL vaccine (yeast). The consumer did not remember when his daughter's first and second dose of GARDASIL vaccine (yeast) were administered. On 20-APR-2008 or 25-APR-2008 the patient was vaccinated with the third dose of GARDASIL vaccine (yeast). The patient experienced muscle aches and pain on GARDASIL vaccine (yeast) and the consumer noticed she had slow movements while walking and getting dressed after her 1st and 2nd dose of GARDASIL vaccine (yeast). The doctor referred her to a rheumatologist, who told her to take high amounts of vitamin D. Lab tests showed her "antibodies went up". The doctor thinks patient has "rheumatism". Patient was getting worse everyday and needs help getting out of bed. Additional information has been requested.  11/06/2008 PCP records received. Pt reports developed irregular periods, knee pain, lower back pain and R wrist pain after 2nd HPV vax . Normal exam 5/5/08. Sent for labs and referred to Rheumatology. OV 5/22/08 with DX:  Acute Arthritis. OV 8/5/08 with c/o decreased energy and parent noticed movements are slower. DX: Vit D deficiency. Fatigue. Rheum consult 7/8/08 for joint pain/(+) ANA. PE (+) for Wrist limitation.     11/12/2008 Rheumatology consults received dated 7/8 and 10/17/2008 with DX: Polyarthritis, chronic. Vit D deficiency. Anemia NOS. Pt presented with gradual onset of bilateral hand, knee, foot and back pain & morning stiffness.  PE (+) for fatigue, generalized weakness, non-productive cough, and wrist limitation. Tx with anti-inflammatory
Bullous Pemphigoid; blisters all over her; can not walk; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 20230717306.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 Immunization. The following information was reported: PEMPHIGOID (medically significant), outcome "unknown", described as "Bullous Pemphigoid"; BLISTER (non-serious), outcome "unknown", described as "blisters all over her"; GAIT DISTURBANCE (non-serious), outcome "unknown", described as "can not walk".  Clinical course: Patient had Pfizer booster, diagnosed with Bullous Pemphigold she has blisters all over her, spending her life savings to get help not covered by her health Ins, cannot walk, using diapers  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A few days after my son received the booster shot, he started to say he didn?t feel good. Almost daily he said that. On 10/31/2021 about 10:15 PM he said his whole torso hurt and he couldn?t breathe well. Finally on 11/01/2021 about 2:15 AM  my son said his heart felt hot. We headed to the local hospital. The X-ray showed a clot in the right lung. 5 days in the hospital on heparin and now daily Eliquis.  Because my son had a blood clot in his leg 2.5 years ago, they said it had to be due to that.  My son started complaining soon after the 3rd shot but we just thought it would go away.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) outcome was unknown. Not Provided    For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that, the vial was initially refrigerated  on 17-Nov-2021, the vial did not undergo any temperature excursion and patient did not experienced any adverse events.  No treatment medications were reported.
Hair shedding and hair loss began to occur about 2 or 3 months after my second Covid-19 shot. The shedding increased to large amounts of hair loss each day over the last 2 months. My hair is continuing to shed currently as of 10/7/2022.
COVID-19; COVID-19; received BNT162B2, BNT162B2 OMI BA.4-5 and Moderna covid-19 vaccine; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient. A 68-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Sep2022 at 19:00 as dose 4 (booster), single (Lot number: GH9702) at the age of 67 years, in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 09Jan2021 at 15:00 as dose 1, single (Lot number: 039K20A), in left arm, on 06Feb2021 at 15:00 as dose 2, single (Lot number: 029K20A), in left arm and on 13Sep2021 as dose 3 (booster), single (Lot number: 004F21A), in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 13Sep2021, outcome "unknown", described as "received BNT162B2, BNT162B2 OMI BA.4-5 and Moderna covid-19 vaccine"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid from 31Jul2023 to 05Aug2023.
Numbness and swelling of the face, throat and hands. No difficulty breathing or swallowing, Denies pain.  Pt reports that symptoms are similar to covid illness in November.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose01/20/21 2nd dose02/10/21 Diagnosed covid positive:08/17/21 Symptom onset:08/14/21 Exposure:Home Symptoms:loss of smell/taste,HA, congestion, cough
Swollen itchy area under left eye.  Itchy left and right jaw.  Rash and itching down right side of neck.  Tingling in left side of face and lips.
The pharmacy discovered that her Second dose of the Moderna COVID-19 vaccination regimen was given 18 days after the initial dose, 10 days earlier than recommended.   The patient was notified and at that time she said she hadn't had any signs or symptoms of an adverse effect.
Sore throat next day and for weeks afterwards (it has not gone away in 2 weeks). Depression since vaccine and continuing.
Received tdap 5 days ago. Noticed left arm to be red, warm to touch, and itchy about 2 days ago. Area of redness 11.5cm x 5.5cm with induration.
Narrative: Patient experienced joint pain and swelling approximately 1 hour after receiving the second COVID-19 vaccine. Patient reported having this hand pain before, but at the time of the reaction it had extended to the wrist and the pain severity had increased
24hrs after immunizations r deltoid area from shoulder to elbow red, edematous and warm to touch.
Patient was light headed, pale and nauseated shortly after receiving her first covid-19 vaccine. Vitals were BP 77/40, HR 46, O2 100%. Patient instructed to lie down, cool compress applied and drank some . Several BP checks and monitoring over the next half hour. After about 30 minutes, patient reports feeling better, denied dizziness, vitals improved (BP 104/65, HR 50, O2 100%). Patient states she has had this type of reaction with another vaccine (specific vaccine that patient had reaction to in the past was not reported).
Hx of Infantile atopic dermatitis, Rash large patches started am of 6/14/19 3 days after vaccination not sure if just dermatitis urticaria secondary to vaccines.
Patient c/o Swelling, redness, warm to touch in injection area, can't lift arm, chills, back pain, and Headache Dr. advised patient to manage with ice and Tylenol 650 mg every 8 hours, add Advil 800 every 8 hours if needed This is an inflammatory response and should be self limited.
10/21 @0500: nasal congestion, headache, cough, temp: 39.2 10/21 @2330: pounding headache, site tender, no redness/ swelling Temp: 39.2 10/22 @0630: diaphoretic teeth chattering, temp: 37.8 p. 108 10/22 @2200 excruciating headche 10/23 c/o R arm pain, states he can't lift his arm d/t pain, area is swollen, red, warm and very sore to touch.
On 9/15/21 my menstrual cycle started around its scheduled time, but I had a heavier menstrual flow, along with painful cramps, pelvic pain, and extreme fatigue. The best way I can compare my cramps and pelvic pain are close to pregnancy contractions. I haven't had this sort of menstrual pain before and my usual dose of Tylenol 1,000mg that I take for my normal menstrual cramps did not alleviate the pain.  It is now day 7 and I still have spotting and pelvic pain on and off (which are both abnormal for me). My usual cycle ends around the 5th day and cramping usually stops after day 2.
minor lightheaded feeling; minor arm soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 25 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 10Mar2021 18:00 (Lot number: EN6199) at the age of 25 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Environmental allergy" (unspecified if ongoing), notes: environmental allergies; "Asthma" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Depression" (unspecified if ongoing). Concomitant medication(s) included: ZOLOFT; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; DAPSONE; EPIDUO FORTE; ALBUTEROL [SALBUTAMOL]. Past drug history included: Chlora-prep/chlorhexidine gluconate, reaction(s): "known allergies: Chlora-Prep/Chlorhexidine gluconate", notes: known allergies: Chlora-Prep/Chlorhexidine gluconate. The following information was reported: DIZZINESS (non-serious) with onset 10Mar2021, outcome "recovered" (11Mar2021), described as "minor lightheaded feeling"; PAIN IN EXTREMITY (non-serious) with onset 10Mar2021, outcome "recovered" (11Mar2021), described as "minor arm soreness". Therapeutic measures were not taken as a result of dizziness, pain in extremity.  Additional Information: The patient had first injection and in first 15 minutes after injection she had very minor lightheaded feeling, and minor arm soreness which lasted for 24 hours.  No follow-up attempts are possible. No further information is expected.
Patient felt an immediate swelling and soreness in left hand in knuckle joints Ice pack applied to area and patient monitored for 30 minutes.
MULTIPLE DOSE/RECEIVED INJECTION BOTH IN LEFT AND RIGHT ARM; LITTLE HOT; OFF-LABEL USE; MEDICATION ERROR; This spontaneous report received from a health care professional concerned a 53 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: UNKNOWN) 0.5 ml, administered on 09-APR-2021 10:00, and 0.5 ml, administered on 09-APR-2021 10:15 for prophylactic vaccination.  No concomitant medications were reported. On 09-APR-2021, the subject experienced multiple dose/received injection both in left and right arm. On 09-APR-2021, the subject experienced little hot. On 09-APR-2021, the subject experienced off-label use. On 09-APR-2021, the subject experienced medication error. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from little hot, and the outcome of multiple dose/received injection both in left and right arm, off-label use and medication error was not reported. This report was non-serious.
5-17-08 - entire back of arm is red from shoulder to elbow. Area was hot and red. Patient complained of itching and pain
Patient's wife called 6/12/2021 stating patient had a really swollen, painful  area underneath her left arm.  It started the day after receiving the shot, 6/10/2021.  It was recommended she be seen by a healthcare professional that day, which would probably be the Emergency department.
Expired vaccine Moderna 0.25mL (opened 11/16/2021) accidentally administered to patient as Moderna booster on 11/17/2021. We contacted caregiver (daughter) and advised to monitor any adverse events. Patient will come back for Moderna booster after couple days.
This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (profuse sweating), MUSCLE SPASMS (Muscle cramping across the chest), DYSPNOEA (Difficulty breathing), BACK PAIN (spread across the upper chest and her back) and MYALGIA (severe muscle pain in shoulder area of the left upper arm and left side of the neck) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history provided.). Concomitant products included METOPROLOL TARTRATE and ESCITALOPRAM for an unknown indication. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced HYPERHIDROSIS (profuse sweating), MUSCLE SPASMS (Muscle cramping across the chest), DYSPNEA (Difficulty breathing), BACK PAIN (spread across the upper chest and her back) and MYALGIA (severe muscle pain in shoulder area of the left upper arm and left side of the neck). On 22-Mar-2021, HYPERHIDROSIS (profuse sweating) had resolved. At the time of the report, MUSCLE SPASMS (Muscle cramping across the chest), DYSPNOEA (Difficulty breathing), BACK PAIN (spread across the upper chest and her back) and MYALGIA (severe muscle pain in shoulder area of the left upper arm and left side of the neck) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information included over-the-counter Aleve and Tylenol. Patient asks if she can get a second dose or not, after having potential adverse reactions to the first dose.
No adverse reaction.  We are reported an administration error.  The administering pharmacist was supposed to administer the new bivalent booster, but he administered the pediatric dose instead.  We have been in contact with Moderna, and they recommended we fill out the VAERS for these incidents.